Page last updated: 2024-10-21

enprofylline and Apnea

enprofylline has been researched along with Apnea in 1 studies

enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.

Apnea: A transient absence of spontaneous respiration.

Research Excerpts

ExcerptRelevanceReference
" caused fetal apnea that was reduced from 143 +/- 45."3.68Influence of prolonged adenosine receptor blockade on fetal sleep and breathing patterns. ( Avital, A; Chernick, V; Jansen, AH; Sitar, DS, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avital, A1
Jansen, AH1
Sitar, DS1
Chernick, V1

Other Studies

1 other study available for enprofylline and Apnea

ArticleYear
Influence of prolonged adenosine receptor blockade on fetal sleep and breathing patterns.
    Respiration physiology, 1993, Volume: 91, Issue:2-3

    Topics: Animals; Apnea; Female; Fetus; Infusions, Intravenous; Phenylisopropyladenosine; Pregnancy; Purinerg

1993